- Home
- FBNC vs CPRX Comparison
FBNC vs CPRX Comparison
Compare FBNC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- CPRX
- Stock Information
- Founded
- FBNC 1934
- CPRX 2002
- Country
- FBNC United States
- CPRX United States
- Employees
- FBNC N/A
- CPRX N/A
- Industry
- FBNC Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- FBNC Finance
- CPRX Health Care
- Exchange
- FBNC Nasdaq
- CPRX Nasdaq
- Market Cap
- FBNC 2.2B
- CPRX 2.6B
- IPO Year
- FBNC N/A
- CPRX 2006
- Fundamental
- Price
- FBNC $51.19
- CPRX $20.82
- Analyst Decision
- FBNC Buy
- CPRX Strong Buy
- Analyst Count
- FBNC 4
- CPRX 5
- Target Price
- FBNC $56.67
- CPRX $33.20
- AVG Volume (30 Days)
- FBNC 220.5K
- CPRX 1.6M
- Earning Date
- FBNC 10-22-2025
- CPRX 11-05-2025
- Dividend Yield
- FBNC 1.80%
- CPRX N/A
- EPS Growth
- FBNC N/A
- CPRX 183.96
- EPS
- FBNC 2.35
- CPRX 1.65
- Revenue
- FBNC $361,053,000.00
- CPRX $558,499,000.00
- Revenue This Year
- FBNC $36.30
- CPRX $16.51
- Revenue Next Year
- FBNC $8.19
- CPRX $9.58
- P/E Ratio
- FBNC $21.81
- CPRX $12.64
- Revenue Growth
- FBNC N/A
- CPRX 28.55
- 52 Week Low
- FBNC $34.50
- CPRX $19.05
- 52 Week High
- FBNC $56.45
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- FBNC 36.87
- CPRX 58.08
- Support Level
- FBNC $51.91
- CPRX $19.05
- Resistance Level
- FBNC $53.41
- CPRX $21.07
- Average True Range (ATR)
- FBNC 1.13
- CPRX 0.59
- MACD
- FBNC -0.33
- CPRX 0.16
- Stochastic Oscillator
- FBNC 1.51
- CPRX 60.27
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).